immune system
N |
• no defects in B cell development in the bone marrow or spleen
|
• store-operated Ca2+ entry (SOCE) in B cells is reduced by~69%
• however, agonist induced Ca2+ oscillations are similar to controls
• residual SOCE activity is not inhibited by 2-aminoethyl diphenyl borate (2-APB)
• anti-IgM mediated NFAT1 translocation is significantly reduced
|
• following anti-IgM stimulation proliferation is similar to controls but cell viability is moderately reduced
• increase in oxygen consumption rate and extracellular acidification rates following B cell receptor activation is significantly blunted
|
homeostasis/metabolism
• store-operated Ca2+ entry (SOCE) in B cells is reduced by~69%
• residual SOCE activity in B cells is not inhibited by 2-aminoethyl diphenyl borate (2-APB)
• however, agonist induced Ca2+ oscillations in B cells are similar to controls
|
hematopoietic system
• store-operated Ca2+ entry (SOCE) in B cells is reduced by~69%
• however, agonist induced Ca2+ oscillations are similar to controls
• residual SOCE activity is not inhibited by 2-aminoethyl diphenyl borate (2-APB)
• anti-IgM mediated NFAT1 translocation is significantly reduced
|
• following anti-IgM stimulation proliferation is similar to controls but cell viability is moderately reduced
• increase in oxygen consumption rate and extracellular acidification rates following B cell receptor activation is significantly blunted
|